Literature DB >> 23583303

The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-α expression.

Bruno K Robbs1, Pedro I Lucena, João P B Viola.   

Abstract

Nuclear factor of activated T cells (NFAT) was described as an activation and differentiation factor in T cells. NFAT1 protein is expressed in several cell types and has been implicated in the control of the cell cycle, death and migration. Overexpression or activation of NFAT1 has been demonstrated to induce cell death in different cell types, such as T lymphocytes, Burkitt's lymphoma, and fibroblasts. Although these findings indicate a role for NFAT1 transcription factor in control of cell death, the precise mechanisms involved in this process regulated by NFAT1 are still poorly understood. The Ras/Raf/MEK/ERK pathway is activated by many growth factors and cytokines that are important in driving proliferation and preventing apoptosis and is widely implicated in cell transformation and cancer development. We show that NFAT1 protein can cooperate with Ras/Raf/MEK/ERK, but not with the JNK, p38 or NFκB pathways in cell death induction. NFAT1 can induce a cell death pathway consistent with apoptosis, which can be shifted to programmed necrosis by caspase inhibitors. Finally, through screening genes involved in cell death regulation, although we determined that TNF-α, TRAIL and PAK7 genes were up-regulated, only TNF-α expression was responsible for cell death in this context. These data suggest that NFAT1 protein activation can shift oncogenic Ras/Raf/MEK/ERK signaling to acting as a tumor suppressor pathway. These data support a potential role for regulating NFAT1 expression in gene therapy in tumors that display an activated Ras pathway, which could lead to more specific, target-directed TNF-α expression and, thus, tumor suppression.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583303     DOI: 10.1016/j.bbamcr.2013.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Authors:  Pedro I Lucena; Douglas V Faget; Emilia Pachulec; Marcela C Robaina; Claudete E Klumb; Bruno K Robbs; João P B Viola
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

Review 2.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

3.  Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.

Authors:  N A Balenga; E Martínez-Pinilla; J Kargl; R Schröder; M Peinhaupt; W Platzer; Z Bálint; M Zamarbide; I G Dopeso-Reyes; A Ricobaraza; J M Pérez-Ortiz; E Kostenis; M Waldhoer; A Heinemann; R Franco
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.

Authors:  Yu-Lan Yeh; Kuan-Ho Lin; V Bharath Kumar; Tamilselvi Shanmugam; Marthandam Asokan Shibu; Ray-Jade Chen; Chia-Hua Kuo; Tsung-Jung Ho; V Vijaya Padma; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2021-04-22       Impact factor: 3.396

5.  c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.

Authors:  C Geismann; F Grohmann; S Sebens; G Wirths; A Dreher; R Häsler; P Rosenstiel; C Hauser; J-H Egberts; A Trauzold; G Schneider; B Sipos; S Zeissig; S Schreiber; H Schäfer; A Arlt
Journal:  Cell Death Dis       Date:  2014-10-09       Impact factor: 8.469

6.  Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.

Authors:  Xiurong Li; Yuhuai Lan; Yan Wang; Minghao Nie; Yanhong Lu; Eryang Zhao
Journal:  Mol Med Rep       Date:  2017-03-14       Impact factor: 2.952

7.  PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cells.

Authors:  Sheng Han; Xinxin Tie; Lingxuan Meng; Yunjie Wang; Anhua Wu
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

8.  Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma.

Authors:  Julio Finalet Ferreiro; Leila Rouhigharabaei; Helena Urbankova; Jo-Anne van der Krogt; Lucienne Michaux; Shashirekha Shetty; Laszlo Krenacs; Thomas Tousseyn; Pascale De Paepe; Anne Uyttebroeck; Gregor Verhoef; Tom Taghon; Peter Vandenberghe; Jan Cools; Iwona Wlodarska
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

9.  Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors.

Authors:  Nora V Lieske; Kristian Tonby; Dag Kvale; Anne M Dyrhol-Riise; Kjetil Tasken
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

10.  2-D08 treatment regulates C2C12 myoblast proliferation and differentiation via the Erk1/2 and proteasome signaling pathways.

Authors:  Hyunju Liu; Su-Mi Lee; Hosouk Joung
Journal:  J Muscle Res Cell Motil       Date:  2021-06-17       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.